Clinical Trials Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Oct 7, 2020; 26(37): 5693-5704
Published online Oct 7, 2020. doi: 10.3748/wjg.v26.i37.5693
Table 2 Lesion characteristics
ParameterValue
Location in pancreas, n (%)
Head27 (67.5)
Body8 (20)
Tail5 (12.5)
Size max (mm), mean (SD)31.5 (12.3)
Echogenicity on EUS, n (%)
Hypoechoic34 (85)
Isoechoic3 (7.5)
Hyperechoic0
Non-homogeneous3 (7.5)
Final diagnosis, n (%)
Pancreatic adenocarcinoma23 (57.5)
Pancreatic metastases16 (15)
Chronic pancreatitis3 (7.5)
Serous cystic neoplasm/serous cystadenoma2 (5)
Pancreatic NET1 (2.5)
Lymphoma1 (2.5)
Solid pseudopapillary neoplasm1 (2.5)
Acinar cell carcinoma1 (2.5)
Mucinous cystic neoplasm1 (2.5)
Intrapancreatic accessory spleen1 (2.5)
Gold standard method, n (%)
Definite EUS-FNB21 (52.5)
Definite EUS-FNB + surgery5 (12.5)
Surgery8 (20)
Clinical follow up6 (15)